Perlstein Lab

Leave no mutation behind

PLab is the first Public Benefit Corporation accelerating precision drug discovery for 5,000+ rare genetic diseases.

  • 1 in 12 people has an orphan disease. 95% of orphan diseases have no treatment.

  • Each disease is caused
    by a spectrum of genetic mutations.

  • Perlstein Lab studies each mutation
    in model organisms to produce precision medicine.

Blog

May in tweets

YC Demo Day marked the beginning of Spring and a new chapter of growth for PLab. For two years (2014 and 2015) we operated not just as a lean startup, but as an ultra-lean startup — you could call it budgetary caloric restriction. Read more about how we made the transition, and the role YC […]